G6PD and colorectal carcinoma: The application of G6PD inhibitors, specifically DHEA (dehydroepiandrosterone) and 6-AN (6-aminonicotinamide), effectively reduced G6PD expression and GSH levels, thereby inhibiting the MDR of doxorubicin resistant CRC cells (Polimeni et al., 2011).